Clinical Trials in Cleveland

Showing 6901-6920 of 19,775 trials

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

NCT03853317

Phase 2, single-arm study to evaluate combination therapy of avelumab, haNK and N-803 in patients with Merkel Cell Carcinoma who have progressed on or after checkpoint inhibitor therapy as assessed by ORR. Patients will receive treatment for a maximum of two years.

Merkel Cell Carcinoma

ImmunityBio, Inc.9 participantsStarted Feb 2020

San Francisco, California, United States • Miami, Florida, United States • Miami, Florida, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Eptinezumab in Participants With Episodic Cluster Headache

NCT04688775

The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH)

Cluster Headache, Episodic

H. Lundbeck A/S231 participantsStarted Dec 2020

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +117 more locations

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Eptinezumab in Participants With Episodic Cluster Headache

Find Trials by Condition in Cleveland

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

HAART Annuloplasty Device Valve Repair Registry

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

A Study of ZN-c5 in Subjects With Breast Cancer

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

Voxelotor Brain Oxygenation and Neurocognitive Study

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)